We would need a trial with a control group to know if it actually works or not. The trial referred to in the article only had two groups that received different versions of the same treatment.

This was the first person to contract the disease in Hong Kong. The first case in the world was in New York.

They used an adeno-associated virus (AAV) to introduce the gene. That probably shouldn’t have been abbreviated in the headline though. Anyway, this news makes me really happy!